Adebayo Salmon A, Steel Helen C, Shai Leshweni J, Eloff Jacobus N
1 Tshwane University of Technology, Pretoria, South Africa.
2 University of Limpopo, Sovenga, South Africa.
J Evid Based Complementary Altern Med. 2017 Oct;22(4):840-845. doi: 10.1177/2156587217717417. Epub 2017 Jul 6.
Peltophorum africanum extracts have been shown to possess many important medicinal benefits, including anti-inflammatory and antiviral activities. However, the mechanism of action is poorly understood. The mechanism of anti-inflammatory action was determined by measuring the synthesis of cytokines in lipopolysaccharide (LPS) stimulated RAW 264.7 macrophage cells in vitro. Compound 1 (CP1), compound 2 (CP2), and fraction F3.3.0 (F3.3.0) significantly reduced the synthesis of interleukin 1β (IL-1β) from RAW 264.7 cells (1.18, 1.32, and 0.92 ng/mL), respectively. Similarly, CP1, CP2, and F3.3.0 inhibited the production of IL-2 and tumor necrosis factor-α (TNF-α) by RAW 264.7 cells (0.41, 0.60, 0.74 and 0.11, 0.27, 0.24 ng/mL, respectively. In addition, CP1 and CP2 had lower cytotoxicity toward RAW 264.7 cells, with CP2 indicating the lowest cytotoxicity (LD = 207.88 µg/mL). The mechanism of action was found to be via the inhibition of pro-inflammation cytokines (IL-1 β and TNF-α). This observation may support the use of P africanum to treat pain-related conditions.
非洲盾柱木提取物已被证明具有许多重要的药用功效,包括抗炎和抗病毒活性。然而,其作用机制尚不清楚。通过在体外测量脂多糖(LPS)刺激的RAW 264.7巨噬细胞中细胞因子的合成来确定其抗炎作用机制。化合物1(CP1)、化合物2(CP2)和组分F3.3.0(F3.3.0)分别显著降低了RAW 264.7细胞中白细胞介素1β(IL-1β)的合成(分别为1.18、1.32和0.92纳克/毫升)。同样,CP1、CP2和F3.3.0抑制了RAW 264.7细胞产生IL-2和肿瘤坏死因子-α(TNF-α)(分别为0.41、0.60、0.74和0.11、0.27、0.24纳克/毫升)。此外,CP1和CP2对RAW 264.7细胞的细胞毒性较低,其中CP2的细胞毒性最低(半数致死剂量=207.88微克/毫升)。发现其作用机制是通过抑制促炎细胞因子(IL-1β和TNF-α)。这一观察结果可能支持使用非洲盾柱木治疗疼痛相关病症。